Holmér Pettersson P, Jakobsson J, Owall A
Department of Cardiothoracic Surgery and Anaesthesiology, Karolinska University Hospital, Stockholm, Sweden.
Acta Anaesthesiol Scand. 2006 Jul;50(6):673-7. doi: 10.1111/j.1399-6576.2006.01043.x.
Paracetamol is commonly used for post-operative pain management in combination with more potent analgesics. The best route of paracetamol administration after major surgery, when oral intake may not be optimal, is not known. Our primary purpose was to study plasma concentrations after the 1st and 4th dose of 1 g of paracetamol given either rectally or intravenously (i.v.) after major surgery.
In this prospective, randomized study, 48 patients undergoing heart surgery were randomized upon arrival to the intensive care unit (ICU) to receive paracetamol every 6th hour either as suppositories or intravenous injections. In half the patients (n = 24), blood samples for paracetamol concentration were obtained before and 20, 40 and 80 min after the first dose. In the other patients (n = 24), additional samples were taken prior to, and at 20, 40, 80 min and 4 and 6 h after, the 4th dose.
Plasma paracetamol concentration peaked (95 +/- 36 micromol/l) within 40 min after initial i.v. administration but did not increase within 80 min after the 1st suppository. Plasma concentration before the 4th dose was 74 +/- 51 and 50 +/- 27 in the rectal and i.v. groups, respectively. Paracetamol concentration peaked 20 min after the 4th dose for the i.v. patients (210 +/- 84 micromol/l) and declined to 99 +/- 27 micromol/l at 80 min as compared with the rectal patients 69 +/- 44 to 77 +/- 48 micromol/l.
Both time course and peak plasma concentrations of paracetamol given rectally differ from the one seen after intravenous administration. The clinical impact of these differences needs further investigation.
对乙酰氨基酚通常与更强效的镇痛药联合用于术后疼痛管理。在大手术后口服摄入可能不理想时,对乙酰氨基酚的最佳给药途径尚不清楚。我们的主要目的是研究大手术后经直肠或静脉注射(i.v.)给予1克对乙酰氨基酚第1剂和第4剂后的血浆浓度。
在这项前瞻性随机研究中,48例接受心脏手术的患者在进入重症监护病房(ICU)时被随机分组,每6小时接受一次对乙酰氨基酚,剂型为栓剂或静脉注射。一半患者(n = 24)在第1剂给药前、给药后20、40和80分钟采集对乙酰氨基酚浓度的血样。另一半患者(n = 24)在第4剂给药前、给药后20、40、80分钟以及4和6小时采集额外血样。
静脉注射初始剂量后40分钟内血浆对乙酰氨基酚浓度达到峰值(95±36微摩尔/升),但第1剂栓剂给药后80分钟内未升高。第4剂给药前,直肠组和静脉注射组的血浆浓度分别为74±51和50±27。静脉注射组患者第4剂给药后20分钟对乙酰氨基酚浓度达到峰值(210±84微摩尔/升),80分钟时降至99±27微摩尔/升,而直肠组患者为69±44至77±48微摩尔/升。
经直肠给予对乙酰氨基酚的时间进程和血浆峰值浓度均与静脉注射给药不同。这些差异的临床影响需要进一步研究。